CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
April 12, 2023 06:30 ET
|
Centogene NV
Aims to resolve patient diagnostic odyssey, often spanning years and multiple misdiagnoses before accurate diagnosisCombines cutting-edge technology and streamlined CE-IVD bioinformatics pipeline with...
CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics
May 23, 2022 06:30 ET
|
Centogene NV
Newly established WGS recommendations published in the European Journal of Human Genetics Collaborative initiative leverages CENTOGENE’s differentiated diagnostic expertise with testing performed in...
PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing
April 04, 2022 09:00 ET
|
PacBio
MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with...
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational Biology
February 23, 2022 09:00 ET
|
PacBio
MENLO PARK, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice...
KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders
February 16, 2022 09:00 ET
|
PacBio
SINGAPORE and MENLO PARK, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- KK Women’s and Children’s Hospital (KKH) and PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing...
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
January 13, 2022 07:00 ET
|
PacBio
MENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice...
PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China
January 11, 2022 07:15 ET
|
Pacific Biosciences of California, Inc.
New collaboration builds on existing relationship between the two companies to develop desktop systems for the clinical market in China Berry Genomics to purchase at least 50 instruments at product...
PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis
January 11, 2022 07:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced a research collaboration with...
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
January 07, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical...
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
January 06, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.; Azenta Life Sciences
MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The...